APA

Kerrigan D., Mantsios A., Grant R., Markowitz M., Defechereux P., La Mar M., Beckham S. W., Hammond P., Margolis D. & Murray M. (20181126). Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. : AIDS and behavior.

Chicago

Kerrigan D, Mantsios A, Grant R, Markowitz M, Defechereux P, La Mar M, Beckham S W, Hammond P, Margolis D and Murray M. 20181126. Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. : AIDS and behavior.

Harvard

Kerrigan D., Mantsios A., Grant R., Markowitz M., Defechereux P., La Mar M., Beckham S. W., Hammond P., Margolis D. and Murray M. (20181126). Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. : AIDS and behavior.

MLA

Kerrigan D, Mantsios A, Grant R, Markowitz M, Defechereux P, La Mar M, Beckham S W, Hammond P, Margolis D and Murray M. Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. : AIDS and behavior. 20181126.